Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

Regenerative Medical Technology (RMTG) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Regenerative Medical Technology (RMTG) over the last 3 years, with Q3 2025 value amounting to $51693.0.

  • Regenerative Medical Technology's Depreciation and Depletion fell 1978.49% to $51693.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $57373.0, marking a year-over-year decrease of 7684.36%. This contributed to the annual value of $123020.0 for FY2024, which is 4212.51% down from last year.
  • Regenerative Medical Technology's Depreciation and Depletion amounted to $51693.0 in Q3 2025, which was down 1978.49% from $30447.0 recorded in Q2 2025.
  • Over the past 5 years, Regenerative Medical Technology's Depreciation and Depletion peaked at $74282.0 during Q3 2023, and registered a low of -$52196.0 during Q4 2024.
  • Moreover, its 3-year median value for Depreciation and Depletion was $51693.0 (2025), whereas its average is $40468.3.
  • Examining YoY changes over the last 5 years, Regenerative Medical Technology's Depreciation and Depletion showed a top increase of 7493.58% in 2024 and a maximum decrease of 17194.78% in 2024.
  • Quarter analysis of 3 years shows Regenerative Medical Technology's Depreciation and Depletion stood at $72547.0 in 2023, then plummeted by 171.95% to -$52196.0 in 2024, then surged by 199.04% to $51693.0 in 2025.
  • Its last three reported values are $51693.0 in Q3 2025, $30447.0 for Q2 2025, and $27429.0 during Q1 2025.